Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 oct. 2016 01h00 HE | Source: Addex Therapeutics

Addex Therapeutics to Conduct Phase IIa Proof of Concept Study of Dipraglurant in Focal Cervical Dystonia

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company Expects to Initiate Study in...
11 oct. 2016 01h00 HE | Source: Addex Therapeutics

Addex Initiates New Study in Collaboration with US National Institute of Drug Abuse with ADX88178 in Non-Human Primate Model of Cocaine Addiction

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 11 October 2016...
30 sept. 2016 01h00 HE | Source: Addex Therapeutics

Addex Therapeutics Reports First Half 2016 Operating Highlights and Financial Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 30 September...
20 sept. 2016 01h00 HE | Source: Addex Therapeutics

Addex Collaborators Published New Data Supporting the Role of Negative Allosteric Modulators of Follicle Stimulating Hormone and Luteinizing Hormone Receptors in Reproductive Health

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 20 September 2016...
27 juil. 2016 01h00 HE | Source: Addex Therapeutics

Addex ADX71441 Demonstrates Positive Results in Highly Translational Preclinical Model of Spasticity.

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 27 July 2016 -...
20 juil. 2016 01h00 HE | Source: Addex Therapeutics

LifeSci Capital Issues Equity Research Report on Addex Therapeutics

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 20 July 2016 -...
24 juin 2016 01h00 HE | Source: Addex Therapeutics

Addex Shareholders Approved all Board Proposals at 2016 Annual General Meeting

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 24 June 2016 -...
13 juin 2016 01h00 HE | Source: Addex Therapeutics

Addex mGluR4 and mGluR7 Programs Demonstrate Potential in Preclinical Models of Neurodegenerative and Psychiatric Diseases

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 13 June 2016...
09 juin 2016 01h00 HE | Source: Addex Therapeutics

Addex ADX71441 Demonstrates Positive Results in Non-Human Primate Model of Cocaine Addiction

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 9 June 2016 -...
08 juin 2016 01h00 HE | Source: Addex Therapeutics

Van Leeuwenhoeck Issues Research Note on Addex Therapeutics

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 8 June 2016 -...

Page précédente